Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 11/09/2026Do you know someone who could benefit from a #SITC membership? Refer them to join SITC with our Connect-a-Colleague Tool! The top referrer receives recognition at #SITC26. sitcancer.org/connect-a-colleague 001
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 15/06/2026Expert SITC speaker Lili Yang, PhD, UCLA is sharing insights on serotonin transporter inhibition at JACI 2026. Explore the latest updates on intratumoral therapies July 22–24, in Kagawa, Japan or virtual. Learn more: ow.ly/Ml0i50Z2ek4 OncoDaily 001
robertferrismdphd.bsky.social @robertferrismdphd.bsky.social · 03/06/2026Congratulations to our new SITC leaders! Very honored and looking forward to working with existing and future leaders, and phenomenal staff to help SITC continue to advance cancer immunotherapies and contribute to this amazing field. @UNC_Lineberger 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 26/05/2026Discuss various approaches to cancer immunity! Organized in collaboration with SITC, the Japanese Association of Cancer Immunology is hosting their 30th Annual Meeting July 22–24 2026, in Kagawa, Japan or virtual. Learn more: ow.ly/G7Wn50Z2e9b 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 21/05/2026Don’t miss the keynote at the 2026 EU Immuno-Oncology Drug Development Summit, on Sept. 3. Join Dr. E. John Wherry as he examines how insights across IO & autoimmune disease are shaping the next generation of therapeutic strategies. Learn more: sitcancer.org/eu-io-summitsitcancer.org/eu-io-summit 021
robertferrismdphd.bsky.social @robertferrismdphd.bsky.social · 20/05/2026Looking forward to a great night of music, dancing and support for SITC at Buddy Guys! It’s become an ASCO tradition! @unclineberger.bsky.social @sitcancer.bsky.social 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 15/05/2026Address logistics and toxicities associated with TIL therapy and CAR T cells! Explore the latest updates in the field with renowned experts during SITC’s ACI: A Focus on Cellular Therapies program May 22. Register now: ow.ly/8HQc50Z09XT Krish Patel, MD Allison Betof Warner, MD, PhD 021
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 13/05/2026Want SITC Swag? Go to ondemand.sitcancer.org & log in to your SITC account and watch OnDemand videos by May 27! You will be entered into a drawing for SITC Swag! Become a SITC Member or purchase a subscription and explore 1,300+ SITC IO videos. More at: www.sitcancer.org/ondemand 001
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 11/05/2026Get to know 2026 SITC At-Large Director candidate Jane Healy, MD, PhD (Merck Sharp & Dohme LLC). Read Dr. Healy’s bio and position statement: www.sitcancer.org/get-involved/2026… 001
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 11/05/2026Dance to your favorite tunes at The CheckPoints performance on May 31 at Buddy Guy’s in Chicago! VIP tickets are available! Your support will benefit the next generation of cancer immunotherapy experts through SITC’s Forward Fund. www.sitcancer.org/about/the-checkpo… 021
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 10/05/2026Explore further details about 2026 SITC At-Large Director candidate, Olivera (Olja) Finn, PhD, FAIO (University of Pittsburgh). Read about Dr. Finn: www.sitcancer.org/get-involved/2026… 012
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 05/05/2026Join us for the Targets for Cancer IO: A Deep Dive Series—an expert-led webinar program exploring cutting-edge science and therapeutic innovation in immuno-oncology. Register now for our three live webinars: www.sitcancer.org/edu/webinars/targ… 001
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 06/05/20262026 Spring Scientific - Next-gen Cellular Therapies, T cell Engagers & Combinations sessions are now on SITC OnDemand! Free for members - join or subscribe for access to 1,300+ IO videos. View Taking TIL into the Next Generation via OnDemand: ondemand.sitcancer.org/media/5f826b... 111
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 06/05/2026Access the latest scientific insights on novel therapeutic applications! Join @bcellbruno.bsky.social and other SITC experts on May 28, for two joint sessions at SIO's 2026 NEXT Summit! SITC members, use code SITC26NEXT for a discounted rates. Learn more: ow.ly/FgZ150YsZkv 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 06/05/2026Be a VIP at The CheckPoints: Rockin’ for a Cure fundraiser on May 31! Get your VIP tickets now for the performance at Buddy Guy’s Legends in Chicago. Donations support the next generation of cancer immunotherapy experts through SITC’s Forward Fund www.sitcancer.org/about/the-checkpo… 001
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 06/05/2026Familiarize yourself with 2026 SITC Vice President candidate Robert Ferris, MD, PhD (The University of North Carolina at Chapel Hill). Read Dr. Ferris’ bio and position statement: www.sitcancer.org/get-involved/2026… 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 06/05/2026@oncodaily.bsky.social @targetedonc.bsky.social 001
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 06/05/2026SITC 2026 Member-only registration is now open! Our 41st Annual Meeting and Pre-Conference Programs feature numerous sessions, speakers, events, exhibits, and awards. Register today for in-person or virtual attendance! sitc.landing.showcare.io/2026-annua… 101
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 07/05/2026Nominate an early career investigator in #immunotherapy today for SITC’s Steven A. Rosenberg Scholars Award. The recipient will be awarded $150k in research funding and recognized during an Award Ceremony at #SITC26. LEARN MORE: sitcancer.org/rosenberg OncoDaily 001
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 07/05/2026Review immunosuppressants for toxicity management! Join a panel of clinical IO experts and discuss the latest updates in the field during SITC’s FREE ACI: A Focus on Toxicity Management program June 16. Register: ow.ly/Noxj50YW3wh Kerry Reynolds, Alessio Cortellini, Elad Sharon, MD, MPH 001
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 08/05/2026Discover more about 2026 SITC Secretary/Treasurer candidate Christian Capitini, MD (University of Wisconsin-Madison and UW Carbone Cancer Center). Read Dr. Capitini’s bio and position statement: www.sitcancer.org/get-involved/2026… 021
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 08/05/2026Dr. Michael T. Lotze, #JITC Editor-in-Chief, is heading to #CIMT 2026! Catch his cutting-edge presentation on cellular therapy May 11, then connect directly during his Meet-the-Editor session immediately after to discuss key strategies for publishing your research. Learn more: ow.ly/wv3I50YWxcI 042
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 09/05/2026Explore further details about 2026 SITC Secretary/Treasurer candidate, Charles (Chuck) Drake, MD, PhD, MS, FAAP (Johnson and Johnson Innovative Medicine). Read about Dr. Drake: www.sitcancer.org/get-involved/2026… 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 05/05/2026Submit your research by June 25 for #SITC26. Multiple oral abstract presentation opportunities available. All accepted abstracts will have the opportunity to present a poster in the Poster Hall and are published in JITC. More information: www.sitcancer.org/2026/abstrac... 111
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 04/05/2026Nominations are open until May 27 for SITC’s Annual Awards. Nominate luminaries for the Richard V. Smalley Award & Lectureship, SITC Lifetime Achievement Award, Tara Withington Public Service Award and the Pedro J. Romero Service to JITC Award www.sitcancer.org/about/awards/awar… 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 30/04/2026Abstract submission deadline for #SITC26 is June 25 for Regular and Early Career Investigator Award Abstracts. 41 abstract travel awards will be awarded. Submit your cutting-edge research today: www.sitcancer.org/2026/abstracts/ab… #SITC26 #immunotherapy 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 30/04/2026SITC’s Academy of Immuno-Oncology nominations are open. The Academy of IO honors individuals who have made seminal contributions to move the field of cancer immunotherapy forward to the benefit of patients. Nominate someone today: www.sitcancer.org/about/awards/awar… 001
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 01/05/2026New Journal for ImmunoTherapy of Cancer article: "Single-cell dissection of persistent tumor antigens in non-responders reveals opportunities for TAA-targeted vaccination after neoadjuvant therapy in esophageal squamous cell carcinoma" jitc.bmj.com/content/14/4... 🧪 041
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 30/04/2026ICYMI: SITC OnDemand is LIVE! SITC members can access more than 1,000 educational IO videos from past SITC events, webinars, virtual summits, annual meetings & more. Visit www.sitcancer.org/OnDemand #SITCOnDemand #SITCQuestfor100 #MemberBenefit OncoDaily 021
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 01/05/2026The 2026 SITC Election is now open! SITC members are electing the society’s next Vice President, Secretary/Treasurer and three At-Large Directors. The election closes on Friday, May 15 at 11:59 p.m. EDT. www.sitcancer.org/get-involved/2026… 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 01/05/2026Do you know an up-and-coming expert in the field of cancer #immunotherapy? Nominate them today for SITC’s Steven A. Rosenberg Scholars Award, one of the society's most prestigious opportunities for early career scientists. More at: sitcancer.org/rosenberg OncoDaily 021
robertferrismdphd.bsky.social @robertferrismdphd.bsky.social · 28/04/2026I would be pleased to contribute to SITC, an amazing society and visionary group of collaborators in any way possible. 010
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 27/04/2026The #SITC election opens May 1. The VP candidate who receives the most votes will begin their 2-year term in 2027 before ascending to the role of SITC President in 2028. Read the biographies + platform statements of this year’s candidates: www.sitcancer.org/get-involved/2026…sitcancer.org2026 SITC Election | Vice President | Secretary/Treasurer | At-Large Directors The 2026 SITC Election will take place May 1–15, 2026. SITC regular or emertius members eligible to vote and help choose the future leaders of the society. 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 27/04/2026New Journal for ImmunoTherapy of Cancer article: "Single-cell and spatial transcriptomics reveal that the CXCL12–CXCR4 axis drives the immune-desert phenotype in small cell lung cancer by recruiting immunosuppressive CXCR4+ neutrophils and S100A8+ monocytes" jitc.bmj.com/content/14/4... #JITC 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 19/04/2026Thank you to everyone who joined our session at #IMMUNOLOGY2026! Your engagement made for a great scientific exchange. Don’t miss the next chance to explore new IO approaches! Join us for Targets for Cancer IO: A Deep Dive series: ow.ly/El8B50YsZfx 031
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 17/04/2026New Journal for ImmunoTherapy of Cancer article: "CD55-expressing myeloid-derived suppressor cells (MDSCs) drive cancer immunoevasion" jitc.bmj.com/content/14/4... 012
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 17/04/2026SITC is at #IMMUNOLOGY2026™! Swing by booth 1031 to learn about #SITC26 and how to make the most of your membership. #immunotherapy 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 16/04/2026We can’t wait to see you at the American Association of Immunologists’ (AAI) #IMMUNOLOGY2026™, April 16-18. Visit booth 1031 to learn about #SITC member benefits, #SITC26, and more! #immunotherapy #cancerresearch 011
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 16/04/2026SITC OnDemand is LIVE! SITC members can access more than 1,000 educational IO videos from past SITC events, webinars, virtual summits, annual meetings & more. Visit www.sitcancer.org/OnDemand #SITCOnDemand #SITCQuestfor100 #MemberBenefit OncoDaily #AACR26 Moffitt Cancer Center 132
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 14/04/2026Early-career researchers, join vibrant discussions and connect with global leaders at Tumor Immunology Meets Oncology! Hosted by Brandenburg Medical School Theodor Fontane in collaboration with SITC, May 7–9 in Germany. Learn more: ow.ly/RLo450YyIiB 022
Reposted by @robertferrismdphd.bsky.socialBernard A. Fox @bernardafox.bsky.social · 24/11/2024Thanks #OncoDaily for the shout out! As noted, no one does this alone. I was incredibly fortunate to have the very best colleagues/friends, students, fellows, supportive philanthropists, & amazing staff at #EACRI & #SITC to work with & together we strove to #FinishCancer. oncodaily.com/blog/184007oncodaily.comBernard Fox received SITC lifetime achievement award - OncoDailyBernard Fox received SITC lifetime achievement award / Bernard Fox, cancer, cancer immunotherapy, Headlines, OncoDaily, Oncology, SITC lifetime achievement 4403
Reposted by @robertferrismdphd.bsky.socialMegen Wittling @megen-w.bsky.social · 24/09/2025Check out our new research on developing a model for tumor infiltrating lymphocyte (TIL) therapy for cholangiocarcinoma (CCA) by the Lesinski and Paulos Labs! @lesinskilab.bsky.social @chrystalpaulos.bsky.social academic.oup.com/jimmunol/adv...academic.oup.comDevelopment of a murine tumor-infiltrating lymphocyte therapy model for cholangiocarcinomaAbstract. Tumor-infiltrating lymphocyte (TIL) therapy is a promising approach, earning U.S. Food and Drug Administration approval in patients with anti–PD- 042
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 03/04/2026Are you an early career investigator looking for funding? Apply now for a one-year, $100,000 2026-2027 SITC Cancer Immunotherapy Fellowship! Letter of Intent due on April 15 #ECR sitcancer.org/fellowships 011
Reposted by @robertferrismdphd.bsky.socialDana-Farber Cancer Institute @danafarber.bsky.social · 05/06/2025In 2023, the @fda.gov approved belzutifan for certain kidney cancers –– thanks to years of work led by Nobel Prize recipient William G. Kaelin Jr., MD. Now, @drchoueiri.bsky.social, director of our Lank Center for Genitourinary Oncology, and team are working to expand its clinical use. bit.lyChain Reaction: The Belzutifan Journey | Dana-Farber Cancer InstituteBasic science discoveries made by Dana-Farber's William G. Kaelin Jr., MD, and his colleagues are propelling powerful new therapies for kidney cancer. 1112
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 01/04/2026Read SITC's latest clinical practice guideline published in the Journal for ImmunoTherapy of Cancer to view up-to-date expert recommendations on ICI treatment and management of RCC:https://ow.ly/wEZW50YzbMj Special thanks to Toni Choueiri, MD, Tian Zhang, MD and the full expert panel. 021
Reposted by @robertferrismdphd.bsky.socialSociety for Immunotherapy of Cancer @sitcancer.bsky.social · 01/04/2026Stay in the know with #SITC! Explore our upcoming events, webinars, and important dates by looking at our calendar. Learn More: sitcancer.org/get-involved/events/c… #Immunotherapy 021
robertferrismdphd.bsky.social @robertferrismdphd.bsky.social · 31/03/2026Exciting and timely SITC sponsored “Advances” meeting! @unclineberger.bsky.social 011
robertferrismdphd.bsky.social @robertferrismdphd.bsky.social · 26/03/2026Comprehensive and updated CPG for RCC! Great for SITC team! 111
Reposted by @robertferrismdphd.bsky.socialLibby Fino @efino87.bsky.social · 02/03/2026The cool thing about Wyoming is how quickly you can disappear into the wilderness when you need to. 1404940337
Reposted by @robertferrismdphd.bsky.socialewsomm.bsky.social @ewsomm.bsky.social · 09/09/2025Kicking off 50 years of @unclineberger.bsky.social with @robertferrismdphd.bsky.social & the 48th Annual Scientific Symposium… looking forward to hearing the amazing reflections on #50years of #cancerresearch! 063
